Net benefit of diagnostic tests for multistate diseases: an indicator variables approach

References

• ADNI. 2020. Study design. Retrieved from Alzheimer’s Disease Neuroimaging Initiative. http://adni.loni.usc.edu/study-design/#background-container.
   Google Scholar
• Alzheimer’s Association. 2019. Alzheimer’s and Dementia: States of Alzheimer’s. https://www.alz.org/alzheimers-dementia/states.
   Google Scholar
• Baker, S. G. 2009. Putting risk prediction in perspective: Relative utility curves. Joournal of the National Cancer Institue 101 (22):1538–1542. doi:10.1093/jnci/djp353.
   PubMedGoogle Scholar
• Baker, S. G., N. R. Cook, A. Vickers, and B. S. Kramer. 2009. Using relative utility curves to evaluate risk prediction. Journal of the Royal Statistical Society (Series A) 172 (4):729–748. doi:10.1111/j.1467-985X.2009.00592.x.
   Google Scholar
• Baker, S. G., and B. S. Kramer. 2012. Evaluating a new marker for risk prediction: Decision analysis to the rescue. Discovery Medicine 14 (76):181–188.
   PubMed Web of Science ®Google Scholar
• Baker, S. G., B. Van Calster, and E. W. Steyerberg. 2012. Evaluating a new marker for risk prediction using the test tradeoff: An update. The International Journal of Biostatistics 8 (1):1–37. doi:10.1515/1557-4679.1395.
   Google Scholar
• Biggerstaff, B. J. 2000. Comparing diagnostic tests: A simple graphic using likelihood ratios. Statistics in Medicine 19 (5):649–663. doi:10.1002/(SICI)1097-0258(20000315)19:5<649:AID-SIM371>3.0.CO;2-H.
   PubMed Web of Science ®Google Scholar
• Blennow, K., H. Hampel, M. Weiner, and H. Zetterberg. 2010. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nature Reviews: Neurology 6 (3):131–144. doi:10.1038/nrneurol.2010.4.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). 2019. What is Dementia? https://www.cdc.gov/aging/dementia/index.html.
   Google Scholar
• Das, P., M. P. Murphy, L. H. Younkin, S. G. Younkin, and T. E. Golde. 2001. Reduced effectiveness of Aβ1-42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiology of Aging 22 (5):721–727. doi:10.1016/S0197-4580(01)00245-7.
   PubMed Web of Science ®Google Scholar
• Duthey, B. 2013. Background paper 6.11: Alzheimer disease and other dementias. A Public Health Approach to Innovation 6:1–74.
   Google Scholar
• Evans, S. R., G. Pennello, N. Pantoja-Galicia, H. Jiang, A. M. Hujer, K. M. Hujer, C. Manca, C. Hill, M. R. Jacobs, L. Chen, et al. 2016. Benefit-risk evaluation for diagnostics: A Framework (BED-FRAME). Clinical Infectious Diseases 63 (6):812–817. doi:10.1093/cid/ciw329.
   PubMed Web of Science ®Google Scholar
• Gail, M. H., and R. M. Pfeiffer. 2005. On criteria for evaluating models of absolute risk. Biostatistics 6 (2):227–239. doi:10.1093/biostatistics/kxi005.
   PubMed Web of Science ®Google Scholar
• Garcia-Alloza, M., M. Subramanian, D. Thyssen, L. A. Borrelli, A. Fauq, P. Das, T. E. Golde, B. T. Hyman, and B. J. Bacskai. 2009. Existing plaques and neuritic abnormalities in APP: PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575. Molecular neurodegeneration 4 (1):19. doi:10.1186/1750-1326-4-19.
   PubMedGoogle Scholar
• Grundman, M., and P. Delaney. 2002. Antioxidant strategies for Alzheimer’s disease. Proceedings of the Nutrition Society 61(2): 191–202.
   Google Scholar
• Holmboe, E. S., and S. J. Durning. 2014. Assessing clinical reasoning: Moving from in vitro to in vivo. Diagnosis 1 (1):111–117. doi:10.1515/dx-2013-0029.
   Google Scholar
• Johns Hopkins Medicine. 2019. Alzheimer’s disease: States of Alzheimer’s. https://www.hopkinsmedicine.org/health/conditions-and-diseases/alzheimers-disease/states-of-alzheimer-disease.
   Google Scholar
• Jutel, A. J., and S. O. h., & illness. 2009. Sociology of diagnosis: A preliminary review. Sociology of Health & Illness 31 (2):278–299. doi:10.1111/j.1467-9566.2008.01152.x.
   PubMed Web of Science ®Google Scholar
• Kantarci, K., S. Weigand, S. Przybelski, M. Shiung, J. L. Whitwell, S. Negash, D. S. Knopman, B. F. Boeve, P. C. O’Brien, R. C. Petersen, et al. 2009. Risk of dementia in MCI: Combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology 72 (17):1519–1525. doi:10.1212/WNL.0b013e3181a2e864.
   PubMed Web of Science ®Google Scholar
• Levites, Y., P. Das, R. W. Price, M. J. Rochette, L. A. Kostura, E. M. McGowan, M. P. Murphy, and T. E. Golde. 2006. Anti-Aβ 42–and anti-Aβ 40–specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. The Journal of Clinical Investigation 116 (1):193–201. doi:10.1172/JCI25410.
   PubMed Web of Science ®Google Scholar
• Liao, C. C., Y. F. Chen, and F. Xiao. 2018. Brain midline shift measurement and its automation: A review of techniques and algorithms. International Journal of Biomedical Imaging 2018. 13. Article ID 4303161. doi:10.1155/2018/4303161.
   Web of Science ®Google Scholar
• McNeil, B. J., and S. J. Adelstein. 1976. Determining the value of diagnostic and screening tests. Journal of Nuclear Medicine 17 (6):439–448. doi:10.1136/jmg.13.6.439.
   PubMed Web of Science ®Google Scholar
• Mitchell, A. J., and M. Shiri-feshki. 2009. Rate of progression of mild cognitive impairment to dementia–meta-analysis of 41 robust inception cohort studies. Acta psychiatrica Scandinavica 119 (4):252–265. doi:10.1111/j.1600-0447.2008.01326.x.
   PubMed Web of Science ®Google Scholar
• Pennello, G., N. Pantoja-Galicia, and S. Evans. 2016. Comparing diagnostic tests on benefit-risk. Journal of Biopharmaceutical Statistics 26 (6):1083–1097. doi:10.1080/10543406.2016.1226335.
   PubMed Web of Science ®Google Scholar
• Pepe, M. S. 2003. The statistical evaluation of medical tests for classification and prediction: Medicine.
   Google Scholar
• Rapsomaniki, E., I. R. White, A. M. Wood, S. G. Thompson, and C. Emerging Risk Factors. 2012. A framework for quantifying net benefits of alternative prognostic models. Statistics in Medicine 31 (2):114–130. doi:10.1002/sim.4362.
   PubMed Web of Science ®Google Scholar
• Roberts, R., and D. S. Knopman. 2013. Classification and epidemiology of MCI. Clinics in Geriatric Medicine 29 (4):753–772. doi:10.1016/j.cger.2013.07.003.
   PubMed Web of Science ®Google Scholar
• Rosenberg, C. E. 2002. The tyranny of diagnosis: Specific entities and individual experience. The Milbank Quarterly 80 (2):237–260. doi:10.1111/1468-0009.t01-1-00003.
   PubMed Web of Science ®Google Scholar
• Samawi, H., D. -G. Chen, F. Ahmed, and J. Kersey. 2021. Medical diagnostics accuracy measures and cut-point selection: An innovative approach based on relative net benefit. Communications in Statistics - Theory and Methods 1–16. doi:10.1080/03610926.2021.2001016.
   Web of Science ®Google Scholar
• Samawi, H. M., J. Yin, H. Rochani, and V. Panchal. 2017. Notes on the overlap measure as an alternative to the youden index: How are they related? Statistics in Medicine 36 (26):4230–4240. doi:10.1002/sim.7435.
   PubMed Web of Science ®Google Scholar
• Shaffer, J. L., J. R. Petrella, F. C. Sheldon, K. R. Choudhury, V. D. Calhoun, R. E. Coleman, P. M. Doraiswamy, and For the Alzheimer’s Disease Neuroimaging Initiative. 2013. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 266 (2):583–591. doi:10.1148/radiol.12120010.
   PubMed Web of Science ®Google Scholar
• Sox, H. C., Jr, L. M. Koran, C. H. Sox, K. I. Marton, F. Dugger, and T. J. Smith. 1989. A medical algorithm for detecting physical disease in psychiatric patients. Psychiatric Services 40 (12):1270–1276. doi:10.1176/ps.40.12.1270.
   Google Scholar
• Tsalik, E. L., Y. Li, L. L. Hudson, V. H. Chu, T. Himmel, A. T. Limkakeng, J. N. Katz, S. W. Glickman, M. T. McClain, K. E. Welty-Wolf, et al. 2016. Potential cost-effectiveness of early identification of hospital-acquired infection in critically ill patients. Annals of the American Thoracic Society 13 (3):401–413. doi:10.1513/AnnalsATS.201504-205OC.
   PubMed Web of Science ®Google Scholar
• Vickers, A. J., and E. B. Elkin. 2006. Decision curve analysis: A novel method for evaluating prediction models. Medical Decision Making 26 (6):565–574. doi:10.1177/0272989X06295361.
   PubMed Web of Science ®Google Scholar
• World Health Organization [WHO]. 2012. International classification of diseases (ICD). Geneva: World Health Organization.
   Google Scholar
• Yin, J., H. M. Samawi, and D. Linder. 2016. Improved estimation of optimal cut-off point associated with youden index using ranked set sampling. Biometrical Journal 58 (4):915–934. doi:10.1002/bimj.201500036.
   PubMed Web of Science ®Google Scholar
• Zhou, X. -H., D. K. McClish, and N. A. Obuchowski. 2009. Statistical methods in diagnostic medicine, Vol. 569. New York: John Wiley & Sons.
   Google Scholar